Cleared Traditional

NESS H200 WIRELESS HAND REHABILITATION SYSTEM USER KIT AND CLINICAN KIT (K111767) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2011
Decision
84d
Days
Class 2
Risk

K111767 is an FDA 510(k) clearance for the NESS H200 WIRELESS HAND REHABILITATION SYSTEM USER KIT AND CLINICAN KIT. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Ness-Neuromuscular Electrical Stimulation Systems (Ra'Anana, IL). The FDA issued a Cleared decision on September 15, 2011 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ness-Neuromuscular Electrical Stimulation Systems devices

Submission Details

510(k) Number K111767 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2011
Decision Date September 15, 2011
Days to Decision 84 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 148d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 60
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K111767.
Synchrony (20-3000)
K242704 · Synapse Biomedical, Inc. · Jun 2025
CIONIC NEURAL SLEEVE (NS-200)
K243828 · Cionic, Inc. · May 2025
Neuvotion NeuStim NN-01
K240632 · Neuvotion, Inc. · Nov 2024
MyndMove, MyndMove 2.0
K233006 · Myndtec, Inc. · Jun 2024
EvoWalk 1.0 System
K230997 · Evolution Devices, Inc. · Dec 2023
Cionic Neural Sleeve NS-100
K221823 · Cionic · Jul 2022